Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Worth Peripherals is in focus ahead of its Q1 FY27 results, with a trading window closure from July 1, 2026, and an Aug 4 board meeting to approve numbers.
Worth Peripherals’ Q1 FY27 numbers are not fully available on some data platforms yet; investors should track NSE/BSE filings while using recent quarterly trends for context.
Pidilite Industries has scheduled its Q1 FY27 results board meeting for August 4, 2026, followed by an earnings call on August 5, alongside key quarterly financial metrics.
KSB Limited posted 1% YoY revenue growth in Q4FY26 but reported a sharp profit decline, while separate BSE filings flagged trading-window closures ahead of results.
KSB reported Q4 FY26 revenue of ₹601.3 crore with lower profit, while the board also flagged an auditor transition and a fresh results approval timeline.
Happy Forgings posted Q1 FY26 revenue of ₹354 crore and PAT of ₹66 crore, aided by 3.8% volume growth and steady realisations of ₹245 per kg.
Prince Pipes schedules an Aug 4, 2026 analyst call to discuss unaudited Q1 FY27 results and reiterates FY27 volume, margin and capex guidance.
AWL Agri Business reported Q1 FY27 revenue of ₹20,048 crore with 7% volume growth, while profit and EBITDA rose sharply, alongside a July 30 earnings call update.
Signpost India reported higher Q1 FY27 profitability, with PAT rising about 22% year-on-year alongside revenue growth and lower depreciation after an accounting policy change.
Manipal Health Enterprises IPO applicants are checking “not allotted” updates as the basis of allotment is due August 3, with refunds and demat credits scheduled next.
Three mainboard IPOs open this week, and investors are tracking subscription multiples, application status, and key dates for allotment and listing on NSE and BSE.
Indian Metals & Ferro Alloys will host its Q1 FY27 earnings call on August 4, 2026, as investors track volume ramp-up and estimates for revenue and profit.
Dr Agarwals Eye Hospital reported Q1FY27 standalone profit growth of 35% on a 22% rise in revenue, with EBITDA up year-on-year and EPS improving.
Morepen Laboratories has scheduled an August 4, 2026 board meeting to approve Q1 FY27 results, following Q4 FY26 revenue growth and a ₹50 crore CDMO dispatch.
Alembic Pharmaceuticals will hold its Q1 FY27 post-results conference call on August 4, 2026, after its board meeting, with dial-in and registration details shared via BSE and NSE filings.
Wonderla Holidays’ upcoming results are due on 4 Aug 2026, with a Rs 2 dividend declared for 7 Aug 2026, following mixed margin trends and detailed Q1 FY26 metrics.